Navigation Links
Clinical Laboratory Management Association's ThinkLab '10 Surpasses Attendance Goals
Date:6/29/2010

CHICAGO, June 29 /PRNewswire/ -- The Clinical Laboratory Management Association (CLMA) is pleased to announce the success of ThinkLab '10, the association's annual meeting, with a 30% increase in attendance and more than 30 new exhibitors.

"ThinkLab '10 surpassed our expectations on all fronts. With robust educational offerings and a packed Exhibit Hall, the event provided attendees with a top-notch professional development opportunity and the chance to meet industry-leading vendors," said C. Anne Pontius, CLMA president. "The post-ThinkLab energy and enthusiasm has been infectious, and I look forward to the continued evolution of our programs and offerings through the rest of this year and beyond."

ThinkLab '10, which was sponsored by Orchard Software, marked the introduction of the CLMA Body of Knowledge for Clinical Laboratory Management, representing the comprehensive set of skills necessary to be a competent laboratory manager. The content of the Body of Knowledge for Clinical Laboratory Management supported the educational offering at ThinkLab '10 and will drive future CLMA educational programming.

Highlights from the post-conference attendee evaluation include:

"This is one of the most informative laboratory meetings that I have been to. There are lots of seminars to choose from and every one that I went to had information that I could take back to my lab and use. Not once did I feel like I was wasting company money!"

"CLMA ThinkLab is a wonderful opportunity to 'recharge your batteries.' It provides many avenues for networking, and the educational programs are excellent. I wish all my managers could attend!"

CLMA will continue the tradition at ThinkLab '11, taking place May 2011 at the Baltimore Convention Center in Baltimore, Maryland. Visit www.clma.org for additional details.

About the Clinical Laboratory Management Association

Founded in 1976, CLMA is an international association of 3,400 clinical laboratory professionals. The association provides leadership in the clinical laboratory industry supporting laboratory professionals through all stages of their careers. CLMA educates and advocates on behalf of its members and plays a leadership role in enhancing the image and increasing the visibility of its profession. CLMA's Vision: CLMA is the premier resource for laboratory professionals, supporting them at any stage of their career. CLMA's Mission: CLMA empowers laboratory professionals to achieve excellence in leadership through forward-thinking educational, networking and advocacy opportunities. For more information, please visit www.clma.org.


'/>"/>
SOURCE Clinical Laboratory Management Association
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Meta-Analysis of SYMLIN(R) Clinical Data Showed No Increased Risk of Cardiovascular Adverse Events Associated With SYMLIN Treatment in Patients With Type 2 Diabetes
2. Corgenix Receives Additional European Patent, Announces Publication of Important Clinical Study on AtherOx(R) Technology
3. Pieris Initiates Phase I Clinical Trial for Lead Anticalin Compound
4. Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study
5. Stemedica Announces the Appointment of Dr. Lev Verkh as Chief Regulatory and Clinical Development Officer
6. Open Source Clinical Trials Software Featured at the 46th DIA Annual Meeting
7. Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting
8. New Cancer Treatments and Combination Therapies Presented by Leading Experts from the John Theurer Cancer Center at the American Society of Clinical Oncology Annual Meeting
9. NewLink Initiates Pivotal Phase 3 Clinical Trial of HyperAcute(R)-Pancreas Immunotherapy for Resected Pancreatic Cancer
10. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial
11. Dendreon Announces Presentation of PROVENGE Data at the American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
Breaking Biology Technology:
(Date:6/2/2016)... --  The Weather Company , an IBM Business (NYSE: ... in which consumers will be able to interact with IBM ... voice or text and receive relevant information about the product ... have long sought an advertising solution that can create a ... and valuable; and can scale across millions of interactions and ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC ... today announced the opening of an IoT Center of ... strengthen and expand the development of embedded iris biometric ... unprecedented level of convenience and security with unmatched biometric ... one,s identity aside from DNA. EyeLock,s platform uses video ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
Breaking Biology News(10 mins):